Pd Rx Financials

Pd Rx Stock Summary

Pd Rx competes with Sweet Earth, and Interpace Biosciences. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. Pd-Rx Pharmaceutical operates under Medical Distribution classification in the United States and is traded on OTC Exchange.

Pd Rx Key Financial Ratios

Pd Rx's financial ratios allow both analysts and investors to convert raw data from Pd Rx's financial statements into concise, actionable information that can be used to evaluate the performance of Pd Rx over time and compare it to other companies across industries.

PDRX Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pd Rx's current stock value. Our valuation model uses many indicators to compare Pd Rx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pd Rx competition to find correlations between indicators driving Pd Rx's intrinsic value. More Info.Pd Rx Pharmaceutical is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.23  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pd Rx Pharmaceutical is roughly  4.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pd Rx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pd Rx's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Along with financial statement analysis, the daily predictive indicators of Pd Rx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pd Rx Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pd Rx Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing PDRX Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pd Rx's daily price indicators and compare them against related drivers.

When running Pd Rx's price analysis, check to measure Pd Rx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd Rx is operating at the current time. Most of Pd Rx's value examination focuses on studying past and present price action to predict the probability of Pd Rx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd Rx's price. Additionally, you may evaluate how the addition of Pd Rx to your portfolios can decrease your overall portfolio volatility.